Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : STEM -- StemCells, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Edscharp who wrote (353)	1/23/2000 3:58:00 PM
From: John Soileau	Read Replies (1) \| Respond to of 805

True it is pre-clinical, but IMO milestones along the way will keep interest up. Successful animal studies would propel the stock bigtime. The important thing is that CTII appears to have grabbed a key position in what will emerge over the next 5 years as one of the hottest, most promising fields in medicine. Harvesting, expansion, and guided stimulation of autologous stem cells, then replacement in the body....that's ultimately going to rid us of some diseases afflicting populations in the tens of millions. I think the market is willing to price future events into the stock-- hey, look at the future earnings currently assumed and priced into Yahoo? I think the odds of CTII getting a piece of the clinical pie are at least as good. A final point--as CTII progresses, they will be more and more valuable to a potential suitor. The big pharmas won't want to be left out of this party and they have huge bucks for acquisitions/licensing deals. What do you think of CTII as a potential acquisition target in the nearer term? John

To: Edscharp who wrote (353)	1/23/2000 11:16:00 PM
From: LLCF	Read Replies (2) \| Respond to of 805

<When we spoke with the company recently, their excitement about the promise of their stem cell technology programs was unmistakable. They also indicated that within the next couple of months, the reasons for their excitement would become much more concrete to the investment community. since the new management took over about two years ago, the company has been very conservative in creating visibility for the research they have been conducting. We trust management, however, and are confident that their promises to share more openly the progress at CTII are sincere. > Cool, worth reposting: "They also indicated that within the next couple of months the reasons for their excitement would become much more concrete to the investment community" Hmmm, add on dips?? DAK